The Institute
Research Institute of Universidade Nova de Lisboa Oeiras Valley Open Institution Research and Advanced Training from Chemistry to Biology Interface with Industry (IBET)
Laborat贸rio Associado status since 2001
2011 Curiosities
2011 Snapshots
Special Awards
Howard Hughes Medical Institute International Early Career Scientist 2012 Karina Xavier
European Research Council Starting Grant 2012 Mariana Gomes de Pinho
Laboratório Associado
ITQB Universidade NOVA de Lisboa | Research and advanced training | Biology & Chemistry IGC
Gulbenkian Foundation | Research and training | Developmental Biology and Biomedicine
IBET Private not for profit | Industry interface | Applied Research | Biotechnology CEDOC Universidade NOVA de Lisboa | Center for Chronic Diseases One of the broadest in scientific expertise, spanning from Chemistry to Medicine, i.e., from “the molecule to the clinical” LA global funding above 30 M€ (45 % from European programs / industry contracts / private)
Our research
Fundamental research and technological development Bio-Organometallics | Catalysis | Supramolecular Chemistry | Drug Design | Drug
Transport | Antibiotic resistance | Microbial Physiology | Molecular Genetics | Pathogenesis | Glycobiology | Protein Crystalography | Protein Modelling | Bioenergetics | Metalloproteins | Ionic Liquids | Biological Risk | Vaccine Development | Biotechnology for Crop Improvement | Plant Genetics | Plant Stress
Our education
Doctoral Course ITQB PhD Program Masters Course in Medical Microbiology (UNL) Masters Course in Science Communication (UNL) Post Graduation Courses in Research Training
Our facilities
NMR National Facility (300 up to 800 MHz) Mass Spectrometry National Facility IBET Pilot Plant (up to 500 L Bioreactors) | GMP and Clean Rooms ITQB/IBET Analytical Services | Microbiology . Chemical Analysis . Protein Characterization | Good Laboratory Practices (GLP)
Our people
190 PhD Holders
26 staff | 29 others | 20 LA | 25 CiĂŞncia | 90 post-docs
160 PhD Students 80 graduates (BI) 25 trainees (master students) 80 Support Staff administrative | technical | scientific
ITQB in numbers
62 Laboratories | 400 Researchers 44 PhD Theses Awarded in 2011
150 Ongoing Funded Research Projects | 3.5 Mâ‚Ź in Research Projects 263 WoS Papers Published in 2011 | 50% with international teams
50 Invited Lectures per Year
Research in numbers
Publications in peer reviewed journals (WoS)
262 224
27 Highly Cited Papers in 2011
194
149
20% national publications in Nature and Science (2006-2010)
55% Q1 articles WoS in 2011
122
130
205
194
186
192
Research in numbers
Citations (WoS)
6620 5942
52,000 total citations 26
7003
5319 4412 3651
average citations/paper
3860
2598
90 h-index
1830
2001
2320
2,800 total papers 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Education in numbers
PhD theses awarded
Total
243
50
45
Other PhD students
40
ITQB PhD studnets
35
12
30 25 20 1
15 10 9
5 0
7
9
4
2
3
4
10
11
12
14
14
26
1
1
20
19
6
27
23
9 11
32
Funding
Total budget in 2011
12,8 M€
Research Projects 26%
Others 8% State Budget 24%
Programa Ciência 16%
Laboratório Associado 26%
Private companies
Alfama (PT, Start-up IBET)
Nanopore Solutions (PT, Start-up ITQB)
AROMICS (ES)
Pfizer (PT)
ADISSEO France S.A.S. (FR)
Hovione (PT)
DSM Nutritional Products (CH)
STAB (PT, Start-up iBET)
ECBIO (PT, Start-up iBET)
Thelial Technologies, S.A. (PT)
GENIBET (PT, Start-up iBET)
Theraproteins (PT, Start-up iBET)
Science and Society
Science Communication: Website | Social Networks | Media Science outreach activities: Open Day | Debates and demonstrations Interactions with schools: Highschool visits | Science in the summer Art & Science: Artistic residences CiĂŞncia Viva partners
Thank you
More information visit www.itqb.unl.pt or
find us on Facebook or Google+